Table 1

Baseline Characteristics and Heparin Dosing for the Study Groups

Group 1 Heparin Discontinued (n = 10)Group 2 Intravenous Heparin Wean (n = 10)Group 3 Subcutaneous Heparin Wean (n = 10)
Age (mean) (yr)6066.265.2
Gender (% male)606080
Weight (kg)79.181.975.6
Admitting diagnosis
 MI6 (60%)6 (60%)6 (60%)
 Unstable angina4 (40%)4 (40%)4 (40%)
Heparin dose (mean)1175 U/h1170 U/h1190 U/h
Heparin dose per kg14.9 U/kg/h14.2 U/kg/h15.7 U/kg/h
Duration of treatment (mean)46.2 h54 h49 h